Review
Copyright ©The Author(s) 2022.
World J Hepatol. Jan 27, 2022; 14(1): 62-79
Published online Jan 27, 2022. doi: 10.4254/wjh.v14.i1.62
Table 1 Factors that influence the surveillance of hepatocarcinoma
Factors existing previous to sustained virological response
Factors existing after sustained virological response
Comorbidities (steatosis, diabetes mellitus, excessive alcohol consumption)Persistently elevated ALT, AST, GGT, alpha-fetoprotein, liver stiffness, FIB-4, APRI, or VITRO
Male genderHypoalbuminemia
Age > 64 yearsIncreasing body weight (?)
F4
Portal hypertension
Elevated FIB-4, APRI, alpha-fetoprotein
History of decompensation
History of IFN therapy (?)
HCV genotypes 1 and 3 (?)